Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Bullboard Posts
Comment by Mofonomoon Sep 29, 2016 4:36pm
223 Views
Post# 25292406

RE:RE:This is pretty ridiculous

RE:RE:This is pretty ridiculousThe news of doubling staff is a mixed bag. 

In the short term (ie. next couple of quarters), the increased staffing levels could cause margins and profits to decrease for several reasons. Incremental sales could lag the additional staffing costs (timing issue). If increased production needs a ramp up or if there are issues with the new manufacturing process that results in damaged or poor quality products (until the bugs are worked out) could also result in decreased profits and margins in the short term. 

Ultimately, in the long run, it is good news with the increased staffing and the new plant opening as revenues and profits will increase but I think today's decline is due to short term investors.

I'm in it for the long run (next few years probably) so these daily fluctuations don't bother me.


Bullboard Posts